A new study provides the first direct biological evidence explaining why some people continue to experience taste loss long after recovering from COVID-19.
Imagine a screening method thatās more accurate in early detection than a mammogram and less expensive than an MRI. Thatās ...
Individuals share their journeys battling cancer and their experiences with groundbreaking immunotherapy treatments.
Researchers identify a reduction in the PLCĪ²2 protein as the cause for long-term sweet, bitter, and umami taste loss in post-COVID patients.
At the start of this year, Rachel Phipps, a 64-year-old retired social worker, decided to forego her health insurance. After ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...
With Khameneiās demise, a hugely consequential chapter in Iranās modern history closes with little certainty over what comes ...
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...
Scientists have identified molecular and structural changes in taste buds that may explain why a small subset of people experience long-term taste loss after COVID-19 infection. The study, published ...
Researchers found reduced PLCĪ²2 and structural damage in taste buds of long-term post-COVID patients. Sweet, bitter, and umami signaling were impaired, while salty and sour pathways stayed intact, ...
A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results